Location History:
- Frederick, MD (US) (2011)
- Bethesda, MD (US) (2012)
Company Filing History:
Years Active: 2011-2012
Title: Susan D. Mertins: Innovator in Renal Cancer Treatment
Introduction
Susan D. Mertins is a prominent inventor based in Bethesda, MD (US). She has made significant contributions to the field of medicine, particularly in the treatment of renal cancer. With a total of 2 patents, her work focuses on innovative methods to combat this serious health issue.
Latest Patents
Mertins' latest patents include groundbreaking methods for treating renal cancer using 4-[bis[2-[(methylsulfonyl)oxy]ethyl]amino]-benzaldehyde. The first patent outlines methods of treating a mammalian subject with renal cancer through the administration of this compound. It also details administration protocols and dosing schedules for effective treatment. The second patent similarly features the use of 4-[bis[2-[(methylsulfonyl)oxy]ethyl]amino]-benzaldehyde, emphasizing the importance of pharmaceutical compositions suitable for these treatment methods.
Career Highlights
Susan D. Mertins is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. Her work at this esteemed institution has allowed her to focus on research that directly impacts patient care and treatment options for renal cancer.
Collaborations
Mertins has collaborated with notable colleagues, including Susan Elaine Bates and David Covell. These partnerships have contributed to her innovative research and the development of effective treatment methods.
Conclusion
Susan D. Mertins stands out as a dedicated inventor in the medical field, particularly in the fight against renal cancer. Her patents and research efforts reflect her commitment to improving patient outcomes through innovative treatments.